IBDEI0J9 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8664,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,8664,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,8665,0)
 ;;=D57.1^^39^401^191
 ;;^UTILITY(U,$J,358.3,8665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8665,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,8665,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,8665,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,8666,0)
 ;;=D75.1^^39^401^189
 ;;^UTILITY(U,$J,358.3,8666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8666,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,8666,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,8666,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,8667,0)
 ;;=C90.30^^39^401^202
 ;;^UTILITY(U,$J,358.3,8667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8667,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,8667,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,8667,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,8668,0)
 ;;=D56.3^^39^401^203
 ;;^UTILITY(U,$J,358.3,8668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8668,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,8668,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,8668,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,8669,0)
 ;;=D56.9^^39^401^204
 ;;^UTILITY(U,$J,358.3,8669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8669,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,8669,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,8669,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,8670,0)
 ;;=D51.2^^39^401^207
 ;;^UTILITY(U,$J,358.3,8670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8670,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,8670,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,8670,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,8671,0)
 ;;=D05.92^^39^401^40
 ;;^UTILITY(U,$J,358.3,8671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8671,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,8671,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,8671,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,8672,0)
 ;;=D05.91^^39^401^42
 ;;^UTILITY(U,$J,358.3,8672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8672,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,8672,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,8672,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,8673,0)
 ;;=D05.90^^39^401^38
 ;;^UTILITY(U,$J,358.3,8673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8673,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,8673,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,8673,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,8674,0)
 ;;=D51.0^^39^401^208
 ;;^UTILITY(U,$J,358.3,8674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8674,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,8674,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,8674,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,8675,0)
 ;;=D51.1^^39^401^209
 ;;^UTILITY(U,$J,358.3,8675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8675,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,8675,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,8675,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,8676,0)
 ;;=D51.9^^39^401^211
 ;;^UTILITY(U,$J,358.3,8676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8676,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,8676,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,8676,2)
 ;;=^5002289
